Role of cytokines in allergic inflammation;Role des cytokines dans la reaction allergique inflammatoire

Revue Francaise d'Allergologie et d'Immunologie Clinique

Volumn 39, Issue 1, 1999, Pages 45-61

  Ponvert, Cl ^a  

^a UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

Allergic reaction; Cytokines; Immediate type hypersensitivity; Inflammation

Indexed keywords

CELL ADHESION MOLECULE; CYTOKINE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G4; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 3; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; INTERLEUKIN 8; LEUKOTRIENE; MACROPHAGE INFLAMMATORY PROTEIN; MONOCYTE CHEMOTACTIC PROTEIN; PROSTAGLANDIN; RANTES; THROMBOCYTE ACTIVATING FACTOR; THROMBOXANE; TUMOR NECROSIS FACTOR ALPHA;

ALLERGY; BASOPHIL; EFFECTOR CELL; ENDOTHELIUM CELL; EOSINOPHIL; HELPER CELL; HUMAN; IMMUNOTHERAPY; INFLAMMATION; MACROPHAGE; MAST CELL; MEDIATOR; REVIEW;

EID: 0033034974     PISSN: 03357457     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0335-7457(99)80040-9     Document Type: Review

References (105)

1. Akoum H., Tsicopoulos A., Vorngt H. et al - Chemokine production by peripheral blood mononuclear cells during rush venom immunotherapy. J. Allergy Clin. Immunol., 1996, 97, 228 (Abst. 183).
2. Alam R., Rozniecki J. - A mononuclear cell-derived histamine-releasing factor in asthmatic patients. Allergy, 1985, 40, 124-129.
3. Alam R., Welter J., Forsythe A. et al - Detection of histamine release-inhibitory factor and histamine-releasing factor-like activities in bronchoalveolar lavage fluids. Am Rev Respir. Dis., 1990, 141, 66-671
4. Altman L.C., Ayars G.H., Baker C., Luchtel D.L. - Cytokines and eosinophil-derived cationic proteins upregulate intercellular adhesion molecule-1 on human nasal epithelial cells. J Allergy Clin Immunol., 1993, 92, 527-536.
5. Bellinghausen I., Metz G., Enk A.H. et al - Insect venom immunotherapy induces interleukin-10 production and a Th2-to-Th1 shift, and changes surface marker expression in venom allergic subjects. Eur. J. Immunol , 1997, 27, 1131-1139.
6. Berger P., Taytard A., Tunon de Lara J M. - Cytokines et allergie immédiate contrôle de la phase tardive. Rev. fr Allergol., 1996, 36, 298-304.
7. Bewtra A., Gupta K - Different levels of IL-1β in atopics as compared to non atopics. J. Allergy Clin Immunol., 1998, 101, S39 (Abst. 169).
8. Bissonnette E.Y., Enciso J.A., Befus D. - TGF-β1 inhibits the release of histamine and tumor necrosis factor-α from mast cells through an autocrine pathway. Am. J Respir. Cell Mol Biol., 1997, 16, 275-282.
9. Borish L., Mascali J., Rosenwasser L.J. - IgE-dependent cytokine production by human peripheral blood mononuclear phagocytes. J. Immunol , 1991, 146, 63-67.
10. Borish L., Mascali J.J., Dishuck J. et al - Detection of alveolar macrophage-derived IL-1β in asthma: inhibition with corticosteroids. J. Immunol , 1992, 149, 3078-3082
11. Bradding P., Feather I.H., Wilson S. et al. - Immunolocalization of cytokines in the nasal mucosa of normal and perennial rhinitic subjects : the mast cell as a source of IL-4, IL-5 and IL-6 in human allergic mucosal inflammation. J. Immunol., 1993, 151, 3853-3865.
12. Bradding P, Roberts J.A., Britten K.M. et al. - Interleukin-4, -5, and -6, and tumor necrosis factor-α in normal and asthmatic airways: evidence for the human mast cell as a source of these cytokines. Am J. Respir. Cell Mol. Biol., 1994, 10, 471-480.
13. Broide D.H., Firestein G.S. - Endobronchial allergen challenge in asthma: demonstration of cellular source of granulocyte/ macrophage colony-stimulating factor by in situ hybridization J. Clin. Invest., 1991, 88, 1048-1053.
14. Broide D.H., Lotz M , Cuomo A.J. et al. - Cytokines in symptomatic asthma airways. J. Allergy Clin. Immunol., 1992, 89, 958-967.
15. Brown P.R - Proinflammatory cytokines in acute asthma. Lancet, 1991, 338, 590-593.
16. Brunet C., Bedard P.M., Lavoie A. et al - Allergic rhinitis to ragweed pollen. II-Modulation of histamine-releasing factor production by specific immunotherapy. J. Allergy Clin Immunol., 1992, 89, 87-94.
17. Casale T.B., Bernstein I L., Busse W.W. et al. - Recombinant human monoclonal anti-IgE therapy in allergie rhinitis. J. Allergy Clin. Immunol , 1996, 97, 199 (Abst. 67).
18. Chand N., Harrison J.E., Rooney S. et al - Anti-IL-5 monoclonal antibody inhibits allergic late phase bronchial eosinophilia in guina pigs: a therapeutic approach. Eur. J. Pharmacol., 1992, 211, 121-123.
19. Chanez P., Godard P., Lacoste J.Y. et al. - Médiateurs et neuromédiateurs dans l'asthme (Revue générale). Presse Med , 1992, 21, 259-265
20. Chihara D., Kurachi D, Hayashi N. et al. - Induction of expression of adhesion molécules on an eosinophilic cell line (EoL-1) by the supernatant of lymphocytes stimulated with specific allergens from asthmatic patients. Int Arch. Allergy Appl. Immunol., 1994, 104, 54-56.
21. [3H] 5HT release. Immunology, 1995, 86, 434-440
22. Conti P., Bouchet W., Feliciani C. et al - Effect of interleukin-1 receptor antagonist (IL-1Ra) on histamine and serotonin release by rat basophilic leukemia cells (RBL-2H3) and peritoneal mast cells. Molec. Cell. Biochem., 1996, 155, 61-68
23. Corrigan C.J., Hamid Q., Kay A.B - Studies on bronchial asthma using the technique of in situ hybridization. Adv. Allergy Clin. Immunol , 1992, 92, 137-145.
24. Coyle A.J., Tsuyuki S., Bertrand C et al. - Mice lacking the IFN-γ receptor have an impaired ability to resolve a lung eosinophilic inflammatory response associated with a prolonged capacity of T cells to exhibit a Th2 cytokine profile. J. Immunol., 1996, 156, 2680-2685
25. Crump J.W. - Bronchoalveolar lavage and lymphocytes in asthma. Eur. respir. J., 1991, 4 (S13), 39-46.
26. Durham S.R., Ying S., Varney V.A. et al. - Cytokine messenger RNA expression for IL-3, IL-4, IL-5 and granulocyte-macrophage colony-stimulating factor in the nasal mucosa after local allergen provocation: relationship to tissue eosinophilia. J. Immunol., 1992, 148, 2390-2394.
27. Fujishima M , Takeuchi T., Shinozaki N. et al. - Measurement of IL-4 in tears of patients with seasonal allergic conjunctivitis and vernal keratoconjunctivitis. Clin. Exp. Immunol , 1995, 102, 395-398.
28. Fukuda T, Nakajima H., Fukushima Y et al. - Detection of IL-5 messenger RNA and interleukin-5 production in bronchial biopsies from asthma by non radioactive in situ hybridization and immunochemistry. J. Allergy Clin. Immunol., 1994, 94, 584-593.
29. Gao J X., Issekutz A.C. - Expression of VCAM-1 and VLA-4 dependent T-lymphocyte adhesion to dermal fibroblasts stimulated with proinflammatory cytokines. Immunology, 1996, 89, 375-383.
30. Ghaffar O., Laberge S., Jacobson M R. et al. - IL-13 mRNA and immunoreactivity in allergen-induced rhinitis: comparison with IL-4 expression and modulation by topical glucorticoid therapy. Am. J. Respir Cell Mol Biol., 1997, 17, 17-24.
31. Gosset P., Tsicopoulos A., Wallaert B. et al - Tumor necrosis factor alpha and interleukin-6 production by human mononuclear phagocytes from allergic asthmatics after IgE-dependent stimulation. Am. Rev. Resp Med., 1992, 146, 768-774.
32. Gosset P., Malaquin F., Delneste Y. et al - Interleukin-6 and interleukin-1α production is associated with antigen-induced late nasal response. J Allergy Clin. Immunol., 1993, 92, 878-890.
33. Grewe M., Walther S., Gyufko K et al - Analysis of the cytokine pattern expressed in situ in inhalant allergen patch test reactions of atopic dermatitis patients. J. Invest. Dermatol., 1995, 105, 407-410.
34. Gupta K, Bewtra A. - Differences in soluble IL-1 receptor type expression between atopics and non-atopics. J Allergy Clin. Immunol., 1998, 101, S39 (Abst 172).
35. Hamid Q, Naseer T., Minshall E M et al. - In vivo expression of IL-12 and IL-13 in atopic dermatitis. J. Allergy Clin Immunol , 1996, 98, 225-231
36. Hellquist H.B., Karlsson M.G. - Nasal memory T lymphocytes capable of producing IL-4 in the allergic reaction. Allergy, 1992, 47, 334-336
37. Hernandez A., Omini C , Daffoncio L. - Interleukin-1β: a possible mediator of lung inflammation and airway hyperreactivity. Pharmacol. Res., 1991, 24, 385-393.
38. Hessel E.M., Van Oosterhout A.J.M., Van Ark I. et al - Development of airway hyperresponsiveness is dependent on interferon-γ and independent of eosinophil infiltration Am. J Respir Cell Mol. Biol., 1997, 16, 325-334.
39. Horie S., Okubo Y., Hossam M. et al - IL-13 but not IL-4 prolongs survival and induces eosinophil chemotaxis. J. Allergy Clin. Immunol , 1996, 97, 303 (Abst. 484).
40. Hu Z Q , Zenda N., Shimamura T. - Down-regulation by IL-4 and up-regulation by IFN-γ of mast cell induction from mouse spleen cells. J Immunol., 1996, 156, 3925-3931
41. Huang S.K., Krishnaswamy G., Nu S N et al - Analysis of cytokine transcripts in the bronchoalveolar lavage cells of patients with asthma. J. Immunol , 1993, 150, 138 (Abst.).
42. Jujo K., Renz H., Abe J. et al. - Decreased interferon-gamma and increased interleukin-4 production in atopic dermatitis promotes IgE synthesis. J. Allergy Clin. Immunol., 1992, 90, 323-331.
43. Jutel M , Pichler W.J., Skrbic D. et al - Bee venom immunotherapy results in decrease of IL-4 and IL-5 and increase of IFN-γ secretion in specific allergen-stimulated T cell cultures. J Immunol., 1995, 154, 4187-4194.
44. Kips J C., Tavernier J., Pauwells R.A. - Tumor necrosis factor causes bronchial hyperresponsiveness in rats. Am. Rev Resp. Dis , 1992, 145, 332-336.
45. Kishimoto S., Shimazu W., Izumi T et al. - Enhanced expression of platelet-activating factor receptor on human eosinophils by interleukin-3, interleukin-5 and granulocyte-macrophage colony-stimulating factor Int. Arch Allergy Immunol , 1996, 111 (S1), 63-65.
46. Klapproth H., Racké K , Wessler I - Acetylcholine and nicotine stimulate the release of granulocyte-macrophage colony-stimulating factor from cultured human bronchial epithelial cells. Naunyn-Schmiedeberg's Arch. Pharmacol., 1998, 357, 472-475
47. Kondo N., Fukutomi O., Agata A. et al - The role of T-lymphocytes in patients with food-sensitive atopic dermatitis. J. Allergy Clin Immunol , 1993, 91, 658-668.
48. Konno S.I , Gonokami Y , Kurokawa M. et al. - Cytokine concentrations in sputum of asthmatic patients Int Arch. Allergy Immunol., 1996, 109, 73-78.
49. Kroegel C , Julius P , Matthys H et al - Endobronchial secretion of IL-13 following local allergen challenge in atopic asthma : relationship to interleukin-4 and eosinophil counts Eur. Respir. J., 1996, 9, 899-904.
50. Kuna P , Alam R , Kuzminska B., Rozniecki J. - The effect of preseasonal immunotherapy on the production of histamine-releasing factor (HRF) by mononuclear cells from patients with seasonal asthma : results of a double-blind, placebo-controlled, randomized study. J Allergy Clin Immunol., 1989, 83, 816-824.
51. Kunkel S L - Interleukin-8 (IL-8) : the major neutrophil chemotactic factor in the lung. Exp. Lung Res , 1991, 17, 17-23.
52. Lack G., Bradley K.L., Hamelmann E. et al. - Nebulized IFN-γ inhibits the development of secondary allergic responses in mice. J Immunol , 1996, 157, 1432-1439.
53. + T cells in acute severe asthma Clin. Exp Allergy, 1996, 26, 138-146.
54. Ledru E., Pestel J., Tsicopoulos A. et al. - Lymphocyte-mediated regulation of platelet activation during desensitization in patients with hymenoptera venom hypersensitivity. Clin Exp Immunol., 1988, 73, 198-203.
55. Levine S.J - Bronchial epithelial cell-cytokine interactions in airway inflammation. J Invest. Med., 1995, 43, 241-249.
56. Li X.M., Chopra R.K., Chou T.Y. et al. - Mucosal IFN-γ gene transfer inhibits pulmonary allergic responses in mice. J Immunol., 1996, 157, 3216-3219.
57. Li D., Wang D , Griffiths-Johnson D A et al. - Eotaxin protein and gene expression in guinea-pig lungs . constitutive expression and upregualtion after allergen challenge. Eur. Respir J , 1997, 10, 1946-1954
58. Liao T.N., Hsieh K H - Altered production of histamine-releasing factor (HRF) activity and responsiveness to HRF after immunotherapy in children with asthma. J. Allergy Clin. Immunol., 1990, 86, 894-901.
59. Lukacs N.W., Strieter R.M., Lincoln P.M et al - Stem cell factor (C. kit-ligand) influences eosinophil recruitment and histamine levels in allergic airway inflammation. J Immunol., 1996, 156, 3945-3951
60. Mac Donald S.M., Lichtenstein L.M , Proud D. et al. - Studies of IgE-dependent histamine-releasing factors : heterogeneity of IgE. J Immunol , 1987, 139, 506-512.
61. Marini M., Vittori E., Hollenborg J., Mattoli S. - Expression of the potent inflammatory cytokines granulocyte-macrophage colony-stimulating factor, interleukin-6 and interleukin-8, in the bronchial epithelial cells of patients with asthma. J. Allergy Clin. Immunol., 1992, 89, 1001-1009.
62. Matsumoto T. - Serum levels of soluble IL-2 receptor, IL-4 and IgE-binding factors in childhood allergic diseases. Clin Exp. Immunol., 1991, 85, 288-292.
63. Matsumoto K., Taki F., Miura M. et al. - Serum levels of soluble IL-2R, IL-4 and soluble FcεRII in adult bronchial asthma. Chest, 1994, 105, 681-686.
64. Miki I., Kusano A., Ohta S et al. - Histamine enhances the TNF-α-induced expression of E-selectin and ICAM-1 on vascular endothelial cells Cell Immunol., 1996, 171, 285-288.
65. Mochizuki M., Bartels J , Mallet A.I. et al. - IL-4 induces eotaxin: a possible mechanism of selective eosinophil recruitment in helminth infection and atopy J Immunol , 1998, 160, 60-68
66. Mor S., Nagler A., Barak V. et al. - Histamine enhances granulocyte-macrophage colony-stimulating factor and interleukin-6 production by human peripheral blood mononuclear cells. J Leukoc. Biol., 1995, 58, 445-450.
67. Mori A., Suko M., Kaminuma O et al - IL-15 promotes cytokine production of human helper T cells. J. Immunol., 1996, 156, 2400-2405.
68. Motojima S., Adachi T., Arima M. et al. - Eosinophil peroxidase stimulates the release of granulocyte-macrophage colony-stimulating factor from respiratory epithelial cells. J. Allergy Clin. Immunol., 1996, 97, 292 (Abst. 440).
69. Nakamura Y., Ozaki T., Kamei T. et al - Increased granulocyte-macrophage colony-stimulating factor production by mononuclear cells from peripheral blood of patients with bronchial asthma Am Rev. Resp Dis , 1993, 147, 87-91.
70. Niggemann B., Zuberbier T., Herz H. et al. - Interleukin-4 (IL-4) enhances and soluble interleukin-4 receptor (sIL-4R) inhibits histamine release from peripheral blood basophils and mast cells in vivo and in vitro Mediat. Inflamm., 1997, 7, 111-118
71. Nilsson G., Hjertson M., Andersson M et al. - Demontration of mast cell chemotactic activity in nasal lavage fluid. characterization of one chemotaxin as c.kit-ligand, stem cell factor. Allergy, 1998, 53, 874-879.
72. Nish W.A., Charlesworth E.N., Davis T.L. et al - The effect of immunotherapy on the cutaneous late phase response to antigen J Allergy Clin Immunol., 1994, 93, 484-493.
73. Numao T., Agrawal D.K. - Neuropeptides modulate human eosinophil chemotaxis. J. Immunol. 1992, 149, 3309-3315.
74. Okada S., Inoue H., Yamauchi K. et al. - Potential role of interleukin-1 in allergen-induced late asthmatic reactions in guinea pigs: suppressive effect of interleukin-1 receptor antagonist on late asthmatic reaction. J Allergy Clin. Immunol., 1995, 95, 1236-1245
75. Park C.S., Lee S.M., Uh S.T. et al - Soluble interleukin-2 receptor and cellular profiles in bronchoalveolar lavage fluid from patients with bronchial asthma. J. Allergy Clin. Immunol., 1993, 91, 623-633.
76. Ponvert C. - Present concepts of the mechanisms of hyposensitization. Rev fr Allergol., 1996, 36, 782-786
77. Ponvert C. - Les cytokines. Rev fr Allergol., 1997, 37, 36-55.
78. Pujol J.L , Cosso B., Daurès J.P. et al - Interleukin-1 release by alveolar macrophages in asthmatic patients and healthy subjects. Int Arch. Allergy Appl Immunol , 1990, 91, 207-210.
79. Reinhold U., Pawelec G., Wehrmann W. et al. - Cytokine release from cultured peripheral blood mononuclear cells of patients with severe atopic dermatitis. Acta Derm. Venereol (Stockh), 1989, 69, 497-502.
80. Renz H., Bradley K., Enssle K. et al. - Prevention of the development of immediate hypersensitivity and airway hyperresponsiveness following in vivo treatment with soluble IL-4 receptor. Int Arch Allergy Immunol , 1996, 109, 167-176.
81. Renzetti L.M., Paciorek P M., Tannu S.A. et al. - Pharmacological evidence for tumor necrosis factor as a mediator of allergic inflammation in the airways. J. Pharmacol Exp. Ther., 1996, 278, 847-853.
82. Ricci M , Rossi O. - Dysregulation of IgE responses and airway allergic inflammation in atopic individuals. Clin. Exp Allergy, 1990, 20, 601-609.
83. Robinson D.S., Durham S R., Kay A.B. - Cytokines in asthma. Thorax, 1993, 48, 845-853.
84. Rousset F., Robert J , Andary M et al - Shifts in interleukin-4 and interferon-γ production by T cells of patients with elevated serum IgE levels, and the modulatory effects of these lymphokines on spontaneous IgE synthesis J. Allergy Clin Immunol , 1991, 87, 58-69
85. Saito H., Asakura K, Ogasawara H et al. - Topical antigen provocation increases the number of immunoreactive IL-4, IL-5 and IL-6 positive cells in the nasal mucosa of patients with perennial allergic rhinitis. Int Arch Allergy Immunol , 1997, 114, 81-85.
86. Sumimoto S., Kawai M , Kasajima Y., Hamamoto T. - Increased plasma tumor necrosis factor-α concentrations in atopic dermatitis Arch. Dis. Child., 1992, 67, 277-279
87. Takizawa H., Ohtoshi T., Kikutani T. et al. - Histamine activates bronchial epithelial cells to release inflammatory cytokines in vitro. Int. Arch Allergy Immunol., 1995, 108, 260-267.
88. Tanaka H , Nagai H., Maeda Y. - Effect of anti-IL-4 and anti-IL-5 antibodies on allergic airway hyperresponsiveness in mice. Life Sci., 1998, 62, 169-174
89. Till S.J., Corrigan C., Huston D. et al. - Grass pollen-induced IL-5 production by blood mononuclear cells (PBMC) is increased in allergic rhinitis and inhibited by immunotherapy J Allergy Clin. Immunol., 1996, 97, 245 (Abst. 250).
90. Tonnel A B., Tsicopoulos A. - Profil de cytokines et désensibilisation. Rev. fr Allergol., 1997, 37, 334-337.
91. Tsicopoulos A., Tonnel A.B., Wallaert B. et al - A circulating suppressive factor of platelet cytotoxic functions after rush immunotherapy in hymenoptera-venom hypersensitivity. J Immunol., 1989, 142, 2683-2688.
92. Tsicopoulos A., Akoum H , Tonnel A.B. - Cytokines et chimiokines au cours de la désensibilisation. Rev fr Allergol., 1998, 37, 1078-1082.
93. Urushibata T., Uesugi K , Yoshino K. et al - Pollinosis: etiologic relationship between excessive IL-4 production and down-regulation of the inflammation-suppressive system. Acta Otolaryngol., (Stockh), 1996, S522, 68-73.
94. Van Oosterhout A.J M., Fattah D., Van Ark I. et al. - Eosinophil infiltration precedes development of airway hyperreactivity and mucosal exsudation after intranasal administration of interleukin-5 to mice. J. Allergy Clin. Immunol., 1995, 96, 104-112.
95. Varney V.A., Hamid Q., Gaga M. - Effects of grass pollen immunotherapy on cytokine mRNA expression during allergen-induced late cutaneous responses J. Clin. Invest., 1993, 92, 644-651.
96. Walker C , Virchow J C., Bruijnzeel P.L B., Blaser K. - T cell subsets and their soluble products regulate eosinophiha in allergic and non allergic asthma J Immunol , 1991, 146, 1829-1835
97. Walker C , Bode E., Boer L et al. - Allergic and non-allergic asthmatics have distinct patterns of T cell activation and cytokine production in peripheral blood and bronchoalveolar lavage. Am Rev Resp. Dis , 1992, 146, 109-115.
98. Wedi B , Elsner J., Czech W. et al. - Modulation of intercellular adhesion molecule-1 (ICAM-1) on the human mast cell line (HMC)-1 by inflammatory mediators Allergy, 1996, 51, 676-684.
99. Wershil B.K , Wang Z.S., Gordon J R., Galli S.J. - Recruitment of neutrophils during IgE-dependent cutaneous late phase reactions in the mouse is mast cell-dependent: partial inhibition of the reaction with antiserum against tumor necrosis factor-α. J Clin Invest., 1991, 87, 446-453.
100. Wühtrich B., Kagi M.K., Joller-Jemelka H. - Soluble CD14 but not interleukin-6 is a new marker for clinical activity in atopic dermatitis. Arch Dermatol Res , 1992, 284, 339-342
101. Yanagida M., Fukamachi H., Ohgami K et al. - Effects of T helper 2-type cytokines, interleukin-3 (IL-3), IL-4, IL-5, and IL-6 on the survival of cultured human mast cells. Blood, 1995, 86, 3705-3714.
102. Yanagida M., Fukamachi H., Takei M. et al. - Interferon-γ promotes the survival and FcεRI-mediated histamine release in cultured mast cells Immunology, 1996, 89, 547-552.
103. Yang P.P., Renzi P M. - IL-2 and lymphocyte-induced eosinophil proliferation and survival in asthmatic patients. J. Allergy Clin. Immunol , 1993, 91, 792-801.
104. Yokote R , Yagi H., Furukawa F., Takigawa M. - Regulation of peripheral blood mononuclear cell responses to Dermatophagoides farinae by substance P in patients with atopic dermatitis. Arch Dermatol. Res., 1998, 290, 191-197.
105. Yokoyama A., Kohno N., Fujino S et al. - Circulating interleukin-6 levels in patients with bronchial asthma. Am. J Respir: Crit Care Med., 1995, 151, 1354-1358.